Repligen (RGEN) Shares Outstanding (2010 - 2026)
Repligen (RGEN) posted quarterly Shares Outstanding (Entity) of $56.4 million for Q2 2026, up 8527.87% year-over-year from $654009.0 in Q2 2025, and little changed quarter-over-quarter from $56.4 million in Q1 2026.
Repligen (RGEN) Shares Outstanding (2010 - 2026) Analysis & Trends
Repligen (RGEN) has reported Shares Outstanding (Entity) for 17 consecutive years, with $56.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Shares Outstanding (Entity) rose 8527.87% year-over-year to $56.4 million; the TTM figure through Jun 2026 stood at $56.4 million (up 8527.87% YoY), while the FY2025 annual figure was $56234.0, up 0.53% from the prior year.
- Shares Outstanding (Entity) steadied at $56.4 million in Q2 2026 per RGEN's latest filing, from $56.4 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $56.4 million in Q2 2026 and bottomed at $55353.0 in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $6.5 million across 5 years, with a median of $56085.5 in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) sank 99.9% — and 2026, when it jumped 13675.85%.
- Repligen's Shares Outstanding (Entity) stood at $55460.0 in 2022, then rose by 0.47% to $55720.0 in 2023, then grew by 0.39% to $55937.0 in 2024, then rose by 0.53% to $56234.0 in 2025, then soared by 100243.33% to $56.4 million in 2026.
- Business Quant data shows RGEN's Shares Outstanding (Entity) at $56.4 million in Q2 2026, $56.4 million in Q1 2026, and $56234.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 354.10 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 274.79 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 486.70 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 145.52 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 857.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 70.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 172.70 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 195.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 517.00 Mn |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn | 56.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56.42 Mn |
| Mar 31, 2026 | 56.35 Mn |
| Dec 31, 2025 | 56,234.00 |
| Sep 30, 2025 | 652,930.00 |
| Jun 30, 2025 | 654,009.00 |
| Mar 31, 2025 | 409,407.00 |
| Dec 31, 2024 | 55,937.00 |
| Sep 30, 2024 | 491,206.00 |
| Jun 30, 2024 | 479,482.00 |
| Mar 31, 2024 | 298,998.00 |
| Dec 31, 2023 | 55,720.00 |
| Sep 30, 2023 | 55,766.00 |
| Jun 30, 2023 | 55,705.00 |
| Mar 31, 2023 | 55,590.00 |
| Dec 31, 2022 | 55,460.00 |
| Sep 30, 2022 | 55,498.00 |
| Jun 30, 2022 | 55,444.00 |
| Mar 31, 2022 | 55,353.00 |
| Dec 31, 2021 | 55.02 Mn |
| Sep 30, 2021 | 55.02 Mn |